Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Clin |
RCV000824703 | SCV000965640 | benign | Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1 | 2019-07-26 | reviewed by expert panel | curation | The NM_001754.4:c.614-34C>T variant has a MAF of 1 (100%) in gnomAD cohort that is >/= 0.0015 (0.15%) (BA1). This variant is detected in homozygous state in gnomAD population database (BP2). This intronic variant is predicted by SSF and MES to lead to either an increase in the canonical splice site score or a decrease of the canonical splice site score by no more than 10% and no putative cryptic splice sites are created (BP4). In summary, this variant meets criteria to be classified as benign. ACMG/AMP criteria applied, ACMG/AMP criteria applied, as specified by the ClinGen Myeloid Malignancy Variant Curation Expert Panel for RUNX1: BA1, BP2, BP4. |
Prevention |
RCV000247072 | SCV000308034 | benign | not specified | 2014-01-03 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001610618 | SCV001838805 | benign | not provided | 2018-06-22 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000824703 | SCV002032876 | benign | Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1 | 2021-11-07 | criteria provided, single submitter | clinical testing | |
KCCC/NGS Laboratory, |
RCV003316393 | SCV004015351 | benign | Acute myeloid leukemia | 2023-07-07 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV001610618 | SCV005310051 | benign | not provided | criteria provided, single submitter | not provided | ||
KCCC/NGS Laboratory, |
RCV000824703 | SCV005881287 | benign | Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1 | 2025-02-01 | criteria provided, single submitter | clinical testing |